Recent Finacing
Recent Raise
Ceptaris Therapeutics is a Malvern, Pennsylvania–based specialty pharmaceutical company developing a proprietary mechlorethamine hydrochloride topical gel for early-stage (I–IIA) mycosis fungoides, with an NDA under FDA review.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
